{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:29:58Z","timestamp":1793608198628,"version":"4.5.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.berh.2026.102133","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:43:54Z","timestamp":1774021434000},"page":"102133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting and preventing clinical psoriatic arthritis"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-1084","authenticated-orcid":false,"given":"Enrique R.","family":"Soriano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3675-5484","authenticated-orcid":false,"given":"Maria Laura","family":"Acosta-Felquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6315-7916","authenticated-orcid":false,"given":"Luis D.","family":"Mazzuoccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2026.102133_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X241295920","article-title":"The impact of psoriatic arthritis on quality of life: a systematic review","volume":"16","author":"James","year":"2024","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"10.1016\/j.berh.2026.102133_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/rheumatology\/ker216","article-title":"Work disability in psoriatic arthritis: a systematic review","volume":"51","author":"Tillett","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.berh.2026.102133_bib3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/bjd\/ljad280","article-title":"How to define a \u2018super-responder\u2019 to biologics in psoriasis studies","volume":"189","author":"Thomas","year":"2023","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2026.102133_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.46497\/ArchRheumatol.2024.10710","article-title":"Unmet needs in psoriatic arthritis, a narrative review","volume":"39","author":"Lopez-Medina","year":"2024","journal-title":"Arch Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/annrheumdis-2021-220865","article-title":"Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis","volume":"81","author":"Acosta Felquer","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"18","key":"10.1016\/j.berh.2026.102133_bib6","doi-asserted-by":"crossref","first-page":"adv00324","DOI":"10.2340\/00015555-3682","article-title":"Incidence of psoriatic arthritis in patients with skin psoriasis and associated risk factors: a retrospective population-based cohort study in Swedish routine clinical care","volume":"100","author":"Lindberg","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.berh.2026.102133_bib7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2021.09.019","article-title":"Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: retrospective analysis of an electronic health records database in the United States","volume":"86","author":"Merola","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2026.102133_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40674-019-00135-9","article-title":"Interventions on modifiable risk factors for the development of psoriatic arthritis","volume":"5","author":"Soriano","year":"2019","journal-title":"Current Treatment Options in Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2026.102133_bib10","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s40744-021-00378-w","article-title":"Predictors, risk factors, and incidence rates of psoriatic arthritis development in psoriasis patients: a systematic literature review and meta-analysis","volume":"8","author":"Zabotti","year":"2021","journal-title":"Rheumatol Ther"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/rheumatology\/keae399","article-title":"Subclinical psoriatic arthritis and disease interception-where are we in 2024?","volume":"64","author":"Lopez-Medina","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.berh.2026.102133_bib12","doi-asserted-by":"crossref","first-page":"103891","DOI":"10.1016\/j.autrev.2025.103891","article-title":"Primordial and primary prevention in rheumatological diseases: the time has come","volume":"24","author":"Scagnellato","year":"2025","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/annrheumdis-2021-221255","article-title":"Intercepting psoriatic arthritis in patients with psoriasis: buy one get one free?","volume":"81","author":"McGonagle","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.berh.2026.102133_bib14","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/ard-2023-224148","article-title":"EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis","volume":"82","author":"Zabotti","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/art.39973","article-title":"The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study","volume":"69","author":"Eder","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2026.102133_bib16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/ard.2008.089367","article-title":"Familial aggregation of psoriatic arthritis","volume":"68","author":"Chandran","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib17","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1038\/s41598-020-61981-5","article-title":"Quantifying differences in heritability among psoriatic arthritis (PsA), cutaneous psoriasis (PsC) and psoriasis vulgaris (PsV)","volume":"10","author":"Li","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2026.102133_bib18","unstructured":"Howe C, Hu J, Chen W, Chen K, Felipe A, Eichman S, et al. Familial aggregation in psoriatic arthritis: phenotypic differences in patients with and without a family history of psoriatic disease. Arthritis Rheumatol.n\/a(n\/a).."},{"issue":"2","key":"10.1016\/j.berh.2026.102133_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12016-012-8303-5","article-title":"The genetics of psoriasis and psoriatic arthritis","volume":"44","author":"Chandran","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/ard.2011.155044","article-title":"Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis","volume":"71","author":"Eder","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-015-0640-3","article-title":"Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype","volume":"17","author":"FitzGerald","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.berh.2026.102133_bib22","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/annrheumdis-2017-211414","article-title":"Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis","volume":"76","author":"Bowes","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2026.102133_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2014.07.002","article-title":"Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes","volume":"95","author":"Okada","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.berh.2026.102133_bib24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","article-title":"Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture","volume":"97","author":"Stuart","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.berh.2026.102133_bib25","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3892\/mmr.2017.6248","article-title":"Role of HLA-B27 in the pathogenesis of ankylosing spondylitis","volume":"15","author":"Chen","year":"2017","journal-title":"Mol Med Rep"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003102","article-title":"Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis","volume":"9","author":"Braun","year":"2023","journal-title":"RMD Open"},{"issue":"7941","key":"10.1016\/j.berh.2026.102133_bib27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41586-022-05501-7","article-title":"Autoimmunity-associated T cell receptors recognize HLA-B\u221727-bound peptides","volume":"612","author":"Yang","year":"2022","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.berh.2026.102133_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/art.39494","article-title":"The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study","volume":"68","author":"Eder","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.det.2024.02.014","article-title":"Prevention of psoriatic arthritis: the need for prospective studies","volume":"42","author":"Wu","year":"2024","journal-title":"Dermatol Clin"},{"issue":"5","key":"10.1016\/j.berh.2026.102133_bib30","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/rheumatology\/keab622","article-title":"Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study","volume":"61","author":"Ogdie","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2026.102133_bib31","doi-asserted-by":"crossref","first-page":"711823","DOI":"10.3389\/fmed.2021.711823","article-title":"Translational research studies unraveling the origins of psoriatic arthritis: moving beyond skin and joints","volume":"8","author":"Bolt","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.berh.2026.102133_bib32","article-title":"Linking skin and joint inflammation in psoriatic arthritis through shared CD8(+) T cell clones","author":"Durham","year":"2025","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41590-025-02351-z","article-title":"Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to joints","volume":"27","author":"Raimondo","year":"2026","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.berh.2026.102133_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"29","key":"10.1016\/j.berh.2026.102133_bib35","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038832","article-title":"Relationship of psoriatic arthritis with nail and scalp involvement in Turkish psoriasis patients: multicentered cross-sectional study","volume":"103","author":"Askin","year":"2024","journal-title":"Medicine (Baltim)"},{"issue":"22","key":"10.1016\/j.berh.2026.102133_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13226880","article-title":"Of psoriatic arthritis development: a holistic overview integrating epidemiological and physiopathological data","volume":"13","author":"Fratton","year":"2024","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.berh.2026.102133_bib37","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2017.04.001","article-title":"Nail findings in patients with psoriatic arthritis: a cross-sectional study with special reference to transverse grooves","volume":"77","author":"Zenke","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.berh.2026.102133_bib38","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1080\/09546634.2021.1942423","article-title":"A clinical perspective on risk factors and signs of subclinical and early psoriatic arthritis among patients with psoriasis","volume":"33","author":"Gottlieb","year":"2022","journal-title":"J Dermatol Treat"},{"issue":"5","key":"10.1016\/j.berh.2026.102133_bib39","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1468-3083.2009.03463.x","article-title":"The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics","volume":"24","author":"Christophers","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.berh.2026.102133_bib40","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3899\/jrheum.111298","article-title":"Psoriatic arthritis and onycholysis \u2013 results from the cross-sectional Reykjavik psoriatic arthritis study","volume":"39","author":"Love","year":"2012","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.semarthrit.2017.05.002","article-title":"Ultrasound entheseal abnormalities at the distal interphalangeal joints and clinical nail involvement in patients with psoriasis and psoriatic arthritis, supporting the nail-enthesitis theory","volume":"47","author":"Acosta-Felquer","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000343607","article-title":"Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy","volume":"225","author":"Aydin","year":"2012","journal-title":"Dermatology"},{"issue":"11","key":"10.1016\/j.berh.2026.102133_bib43","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/ddg.12989","article-title":"Nail involvement can predict enthesopathy in patients with psoriasis","volume":"14","author":"Castellanos-Gonz\u00e1lez","year":"2016","journal-title":"JDDG J der Deutschen Dermatol Gesellschaft"},{"issue":"4","key":"10.1016\/j.berh.2026.102133_bib44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1203475415573663","article-title":"Psoriatic nail changes are associated with clinical outcomes in psoriatic arthritis","volume":"19","author":"Sandre","year":"2015","journal-title":"J Cutan Med Surg"},{"issue":"8","key":"10.1016\/j.berh.2026.102133_bib45","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2026.102133_bib46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/rheumatology\/kel214","article-title":"The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis\u2013a high-resolution MRI and histological study","volume":"46","author":"Tan","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.berh.2026.102133_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/nutd.2012.26","article-title":"The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies","volume":"2","author":"Armstrong","year":"2012","journal-title":"Nutr Diabetes"},{"issue":"12","key":"10.1016\/j.berh.2026.102133_bib48","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.jid.2017.07.822","article-title":"Obesity, waist circumference, weight change, and risk of incident psoriasis: prospective data from the HUNT Study","volume":"137","author":"Snekvik","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40744-020-00215-6","article-title":"A narrative review","volume":"7","author":"Kumthekar","year":"2020","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.berh.2026.102133_bib50","article-title":"The obesity\u2013inflammation axis in psoriatic disease: mechanisms and therapeutic strategies","author":"Haberman","year":"2025","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2026.102133_bib51","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/annrheumdis-2012-201299","article-title":"Obesity and the risk of psoriatic arthritis: a population-based study","volume":"71","author":"Love","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2026.102133_bib52","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/annrheumdis-2011-201273","article-title":"Obesity and risk of incident psoriatic arthritis in US women","volume":"71","author":"Li","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2026.102133_bib53","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/acr.20496","article-title":"Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis","volume":"63","author":"Eder","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.berh.2026.102133_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11926-020-00891-x","article-title":"From psoriasis to psoriatic arthritis: insights from imaging on the transition to psoriatic arthritis and implications for arthritis prevention","volume":"22","author":"Zabotti","year":"2020","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"10.1016\/j.berh.2026.102133_bib55","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/rheumatology\/ker078","article-title":"High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case\u2013control study","volume":"50","author":"Naredo","year":"2011","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib56","first-page":"29","article-title":"Detection of subclinical enthesitis by ultrasonography in patients with psoriasis and controls","volume":"3","author":"Silte Karamanlioglu","year":"2024","journal-title":"ARP Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib57","article-title":"Subclinical enthesopathy in Psoriasis-An ultrasonographic study","volume":"12","author":"Dascalu","year":"2024","journal-title":"Med Sci (Basel)"},{"issue":"4","key":"10.1016\/j.berh.2026.102133_bib58","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/art.40778","article-title":"Regression of peripheral subclinical enthesopathy in therapy-naive patients treated with ustekinumab for moderate-to-severe chronic plaque psoriasis: a fifty-two-week, prospective, open-label feasibility study","volume":"71","author":"Savage","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2026.102133_bib59","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3899\/jrheum.110505","article-title":"Preliminary evidence that subclinical enthesopathy May predict psoriatic arthritis in patients with psoriasis","volume":"38","author":"Tinazzi","year":"2011","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2026.102133_bib60","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1136\/annrheumdis-2015-208821","article-title":"Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis","volume":"75","author":"Faustini","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2026.102133_bib61","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s10067-019-04445-0","article-title":"Subclinical synovitis and enthesitis in psoriasis patients and controls by ultrasonography in Saudi Arabia; incidence of psoriatic arthritis during two years","volume":"38","author":"Elnady","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2026.102133_bib62","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1093\/rheumatology\/keaf307","article-title":"Clinical and ultrasound features of a cohort of psoriasis patients without musculoskeletal symptoms: a prospective and multicentre study","volume":"64","author":"Azuaga","year":"2025","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2026.102133_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001067","article-title":"Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia","volume":"5","author":"Zabotti","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2026.102133_bib64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4419-0298-6_4","article-title":"The enthesis organ concept and its relevance to the spondyloarthropathies","volume":"649","author":"Benjamin","year":"2009","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10.1016\/j.berh.2026.102133_bib65","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.berh.2014.10.009","article-title":"The role of mechanical stress in the pathogenesis of spondyloarthritis and how to combat it","volume":"28","author":"Jacques","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2026.102133_bib66","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","article-title":"Enthesitis: from pathophysiology to treatment","volume":"13","author":"Schett","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib67","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/annrheumdis-2016-209334","article-title":"Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis","volume":"76","author":"Thorarensen","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2026.102133_bib68","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","article-title":"Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells","volume":"73","author":"Jacques","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib69","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/annrheumdis-2017-211625","article-title":"Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study","volume":"77","author":"Nguyen","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib70","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/art.39973","article-title":"The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study","volume":"69","author":"Eder","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2026.102133_bib71","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/art.39800","article-title":"Brief report: CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis","volume":"68","author":"Abji","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2026.102133_bib72","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/acr.25539","article-title":"Association of higher levels of high-sensitivity C-Reactive protein with future development of psoriatic arthritis in psoriasis: a prospective cohort study","volume":"77","author":"Eder","year":"2025","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib73","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.23298","article-title":"Differentiating psoriatic arthritis from psoriasis without psoriatic arthritis using novel serum biomarkers","volume":"70","author":"Cretu","year":"2018","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1559-0275-12-1","article-title":"Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers","volume":"12","author":"Cretu","year":"2015","journal-title":"Clin Proteom"},{"key":"10.1016\/j.berh.2026.102133_bib75","doi-asserted-by":"crossref","first-page":"696415","DOI":"10.1155\/2014\/696415","article-title":"S-calprotectin (S100A8\/S100A9): a potential marker of inflammation in patients with psoriatic arthritis","volume":"2014","author":"Hansson","year":"2014","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib76","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13075-017-1417-7","article-title":"Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study","volume":"19","author":"Jadon","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib77","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12967-021-03006-x","article-title":"Identification of proteins associated with development of psoriatic arthritis in peripheral blood mononuclear cells: a quantitative iTRAQ-based proteomics study","volume":"19","author":"Zhu","year":"2021","journal-title":"J Transl Med"},{"issue":"6","key":"10.1016\/j.berh.2026.102133_bib78","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.42661","article-title":"Derivation of a multivariable psoriatic arthritis risk estimation tool (PRESTO): a step towards prevention","volume":"77","author":"Eder","year":"2025","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40744-024-00729-3","article-title":"Evaluation of the \"Multivariable Psoriatic Arthritis Risk Estimation Tool\" in a cohort of patients with psoriasis: preliminary results of a prospective observational study","volume":"12","author":"Lubrano","year":"2025","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.berh.2026.102133_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.740968","article-title":"Predicting the risk of psoriatic arthritis in plaque psoriasis patients: development and assessment of a new predictive nomogram","volume":"12","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2026.102133_bib81","doi-asserted-by":"crossref","first-page":"1426127","DOI":"10.3389\/fimmu.2024.1426127","article-title":"Early detection of psoriatic arthritis in patients with psoriasis: construction of a multifactorial prediction model","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.berh.2026.102133_bib82","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13555-021-00663-0","article-title":"Development of a predictive model for screening patients with psoriasis at increased risk of psoriatic arthritis","volume":"12","author":"Wang","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.berh.2026.102133_bib83","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ard.2025.05.688","article-title":"POS0301 developing and externally validating a multivariable prediction model to predict the risk of developing psoriatic arthritis in adults newly diagnosed with psoriasis in primary care: an observational cohort study","volume":"84","author":"Vivekanantham","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.berh.2026.102133_bib84","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/oby.21955","article-title":"Bariatric surgery and the incidence of psoriasis and psoriatic arthritis in the Swedish obese subjects study","volume":"25","author":"Maglio","year":"2017","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"10.1016\/j.berh.2026.102133_bib85","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jamasurg.2016.4610","article-title":"Incidence and prognosis of psoriasis and psoriatic arthritis in patients undergoing bariatric surgery","volume":"152","author":"Egeberg","year":"2017","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.berh.2026.102133_bib86","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.mehy.2011.09.011","article-title":"Gastric bypass surgery: improving psoriasis through a GLP-1-dependent mechanism?","volume":"77","author":"Faurschou","year":"2011","journal-title":"Med Hypotheses"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib87","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjd.18227","article-title":"Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis","volume":"182","author":"Green","year":"2020","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib88","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13075-019-1810-5","article-title":"Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study","volume":"21","author":"Klingberg","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"suppl 9","key":"10.1016\/j.berh.2026.102133_bib89","article-title":"Dietary interventions in psoriatic arthritis: a randomized controlled clinical trial [abstract]","volume":"77","author":"Eder","year":"2025","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib90","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/annrheumdis-2021-219961","article-title":"Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis","volume":"81","author":"Gisondi","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2026.102133_bib91","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/art.41946","article-title":"Incidence of psoriatic arthritis among patients receiving biologic treatments for psoriasis: a nested case-control study","volume":"74","author":"Rosenthal","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2026.102133_bib92","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s40744-024-00680-3","article-title":"From psoriasis to psoriatic arthritis: decoding the impact of treatment modalities on the prevention of psoriatic arthritis","volume":"11","author":"Watad","year":"2024","journal-title":"Rheumatol Ther"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib93","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/rheumatology\/keae257","article-title":"Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development","volume":"64","author":"Floris","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.berh.2026.102133_bib94","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1093\/rheumatology\/keaf364","article-title":"TNF-alpha inhibitors reduce the incidence of PsA in patients with psoriasis: a propensity score-matched cohort study","volume":"64","author":"Piaserico","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.berh.2026.102133_bib96","doi-asserted-by":"crossref","first-page":"AB1","DOI":"10.1016\/j.jaad.2023.07.016","article-title":"42744 Do biologics for psoriasis prevent the development of psoriatic arthritis? A population-based study","volume":"89","author":"Miao","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2026.102133_bib95","doi-asserted-by":"crossref","first-page":"105833","DOI":"10.1016\/j.jbspin.2024.105833","article-title":"Early methotrexate treatment for psoriatic arthritis prevention in psoriasis patients - a retrospective cohort study","volume":"92","author":"Bar","year":"2025","journal-title":"Jt Bone Spine"},{"issue":"4","key":"10.1016\/j.berh.2026.102133_bib97","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2665-9913(23)00034-6","article-title":"Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study","volume":"5","author":"Singla","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.berh.2026.102133_bib98","article-title":"Psoriatic arthritis risk in psoriasis patients receiving anti-IL-23 vs anti-IL-17: comparison of drug classes and individual agents","author":"Lin","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.berh.2026.102133_bib99","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jaad.2024.06.106","article-title":"Risk of developing inflammatory arthritis in patients with psoriasis initiating treatment with biologics: a population-based analysis","volume":"91","author":"Strober","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40259-024-00689-8","article-title":"Effect of biological therapy for psoriasis on the development of psoriatic arthritis: a population-based cohort study","volume":"39","author":"Cho","year":"2025","journal-title":"BioDrugs"},{"key":"10.1016\/j.berh.2026.102133_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.ard.2025.01.006","article-title":"Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics","author":"Gisondi","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2026.102133_bib102","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.jaad.2025.02.049","article-title":"Risk of psoriatic arthritis among patients receiving apremilast versus methotrexate for psoriasis","volume":"92","author":"Zhao","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib103","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13075-019-1957-0","article-title":"Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation\u2014data from the prospective IVEPSA study","volume":"21","author":"Kampylafka","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.berh.2026.102133_bib104","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13555-021-00650-5","article-title":"Arthritis interception in patients with psoriasis treated with Guselkumab","volume":"12","author":"Zabotti","year":"2022","journal-title":"Dermatol Ther"},{"issue":"12","key":"10.1016\/j.berh.2026.102133_bib105","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063650","article-title":"Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial","volume":"12","author":"Haberman","year":"2022","journal-title":"BMJ Open"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:14:32Z","timestamp":1793607272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694226000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":105,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1521694226000185"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2026.102133","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting and preventing clinical psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2026.102133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102133"}}